Newark, New Castle, USA, March 13, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global contract development and manufacturing organization (CDMO) market is expected to clock US$ 333.85 billion by 2030 and to grow at a CAGR of 8.65% during the forecast period.
The global contract development and manufacturing organization (CDMO) market is primarily driven by the emerging pharmaceutical & biotechnology industry, increasing drug patent expiration, and growing demand for generic drugs. Additionally, increasing investment in research & development and strategic partnership amongst the key players are contributing to the growth of the global contract development and manufacturing organization (CDMO) market. However, strict regulations and the high cost of establishing a factory hold back the growth of the global contract development and manufacturing organization (CDMO) market.
Request Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/contract-development-and-manufacturing-organization-cdmo-market/8071
| Report Attribute | Details |
| Market size value in 2021 | US$ 158.2 billion |
| Revenue forecast in 2030 | US$ 333.85 billion |
| Growth Rate | CAGR of 8.65% from 2022 to 2030 |
| Base year for estimation | 2021 |
| Forecast period | 2022-2030 |
| Segments covered | Service and Region |
| Regional scope | North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
A pharmaceutical contract development and manufacturing organization (CDMO) is a business that specializes in providing services, such as drug product development & manufacturing and pharmaceutical packaging services, with complete trust and transparency. Fully integrated CDMOs offer a variety of contract services, including pre-formulation, formulation development, stability studies, method development, pre-clinical & clinical phase materials, formal stability, scale-up, registration batches, and commercial manufacturing.
Growth Drivers
Increasing demand for generic drugs is contributing to the growth of the global contract development and manufacturing organization (CDMO) market. Generic drug medication is identical to a branded drug which has a similar dose form, potency, mode of administration, quality, performance characteristics, and intended use. The way a generic drug functions and the clinical benefit, it offers are identical to those of a brand-name drug. As generic drug applicants do not need to duplicate the animal and clinical (human) trials that were necessary for brand-name medications to demonstrate safety and efficacy, generic medications typically cost less than their brand-name equivalents. Generic medications are often sold at significant discounts, an estimated 80 to 85% less than the price of the branded medication, due to the reduction in upfront research expenditures.
The global contract development and manufacturing organization (CDMO) market has been analyzed from two different perspectives – Service and Region
Excerpts from ‘by Service’
The global contract development and manufacturing organization (CDMO) market based on type has been segmented into:
- Contract Manufacturing Organization (CMO)
- Contract Research Organization (CRO)
Contract manufacturing organization (CMO) is further segmented into API manufacturing, finished product manufacturing, and packaging services. API manufacturing dominates the global contract development and manufacturing organization (CDMO) market owing to increased demand for active pharmaceutical ingredients, the development of novel therapeutics, and the trend toward new high-tech therapies. Additionally, increasing investment in research & development of novel drug delivery systems and rising demand for personalized medications are also fueling the global contract development and manufacturing organization (CDMO) market. For instance, in Jan 2022, Piramal Pharma Limited (PPL) invested US$ 13.7 million in Hyderabad, India-based Yapan Bio to augment its CDMO business, Piramal Pharma Solutions (PPS). With this investment, PPL holds a 27.78% equity stake in Yapan Bio.
Excerpts from ‘by Region Segmentation
The global contract development and manufacturing organization (CDMO) market has been segmented into:
- North America
- Europe
- Asia Pacific
- Rest of the World
The global contract development and manufacturing organization (CDMO) market is dominated by North America, followed by Asia Pacific. The large share of North America in the global market is attributed to the growing presence of the key player, increasing demand for biologics and pharmaceutical drugs. Additionally, advanced healthcare systems and developed infrastructure are boosting the contract development and manufacturing organization (CDMO) market.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/contract-development-and-manufacturing-organization-cdmo-market/8071
Excerpts from ‘Competitive Landscape’
The prominent players operating in the global contract development and manufacturing organization (CDMO) market are:
- Catalent Inc
- Baxter International Inc
- Vetter
- AbbVie Inc
- Recipharm AB
- Albany Molecular Research Inc. (AMRI)
- Thermo Fisher Scientific Inc. (Patheon)
- Unither
- DPT LABORATORIES LTD.
- NextPharma Technologies
- Samsung Biologics
- Fujifilm Corporation
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) MARKET - ANALYSIS & FORECAST, BY SERVICE
- Contract Manufacturing Organization (CMO)
- API Manufacturing
- Finished Product Manufacturing
- Solid Dosage Forms
- Injectables
- Others
- Packaging
- Contract Research Organization (CRO)
- Discovery
- Preclinical
- Clinical
- Laboratory Services
- Contract Manufacturing Organization (CMO)
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8071
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at - https://www.growthplusreports.com/report-store
Browse related reports:
Mucopolysaccharidosis Type I Market by Treatment Type (Enzyme Replacement Therapy, Allogeneic HSCT), End-user (Hospitals, Speciality Clinics) - Global Outlook and Forecast 2023-2031
Molecular Biology Enzymes, Kits, and Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Cloning), End-user (Hospitals and Diagnostic Centers) – Global Outlook & Forecast 2023-2031
Mental Health Apps Market by Platform Type (iOS, Android), Application (Depression and Anxiety Management, Meditation Management) – Global Outlook & Forecast 2023-2031
Ketone Supplements Market by Form (Solids, Liquids), Type (Esters, Salts, Others), Distribution Channel (Pharmacy/Drug Store, Departmental Store) – Global Outlook & Forecast 2023-2031
Intraoperative Neuromonitoring Market by Type (Outsource Monitoring, Insource Monitoring), Application (Spinal Surgery, Orthopedic Surgery), End-user (Hospitals, Ambulatory Care Centers) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
